Stay updated on Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedShow glossary toggle added; new labels include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' while the previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.4, replacing v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded extensive Location sections listing study sites by country/region (e.g., United States by state, Argentina provinces, Australia states, Mexico regions, etc.), and noted the Revision: v3.3.3.SummaryDifference2%

- Check66 days agoChange DetectedUpdated page copy notes that PubMed publications are automatically filled in from a public database and adds the revision label v3.3.2. The previous PubMed-related wording has been replaced with updated language indicating automatic PubMed linkage and the older revision label v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a new publication citation Grimm MO et al. in Publications; removed an administrative notice about government funding and NIH operations.SummaryDifference0.2%

- Check87 days agoChange DetectedNo significant updates to the study design, objectives, or results were detected. The changes appear to be routine updates to the list of participating sites.SummaryDifference0.2%

Stay in the know with updates to Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab & Cabozantinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.